Elucidating the Roles of Lon Protease and its Substrate, MarA, in Response to salicylate and other Compounds in Escherichia coli by Bhaskarla, Chetana
i | P a g e  
 
SYNOPSIS 
 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Synopsis of research work conducted by B. Chetana (SR No. 011-110-081-06369) 
towards completion of Ph.D. degree under the supervision of Prof. Dipankar Nandi 
at the Department of Biochemistry, Indian Institute of Science, Bangalore, India-
560012 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 
 
Elucidating the roles of Lon protease and its 
substrate, MarA, in response to salicylate and other 
compounds in Escherichia coli 
 
 
Cytosolic protein degradation is crucial for cellular homeostasis as it orchestrates 
protein turnover by destruction of misfolded, unstable and abnormal proteins. This 
process has two main stages: (i) an ATP-dependent stage mediated by unfoldases and 
proteases, and (ii) an ATP-independent stage mediated by various peptidases. The 
ATP dependent proteases recognise target proteins and cleave them into smaller 
peptides. These enzymes comprise the ATPase-family-associated-with-various-
cellular-activities domain that is important for unfolding target proteins. 
Subsequently, unfolded proteins enter a barrel-shaped proteolytic chamber, an 
architecture conserved throughout prokaryotes, archea and eukaryotes, where the 
peptide bond is hydrolysed in an ATP-independent manner. The smaller peptides 
released are broken down by ATP-independent peptidases into free amino acids 
recycled into the cellular pool. In prokaryotes, major cellular protein degradation 
functions are performed by Clp and Lon proteases. 
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Earlier studies in our laboratory have shown the role of an ATP-independent 
peptidase, AminopeptidaseN, in sodium salicylate (NaSal) induced growth inhibition. 
NaSal belongs to the family of Non-Steroidal Anti-Inflammatory Drugs and its acetyl 
ester, Aspirin, is a very widely used analgesic. It is produced by plants as a defence 
response and is known to cause different effects, including xenobiotic stress i. e. stress 
mediated by compounds which are not naturally produced or expected to be present 
in the organism in bacteria. In bacteria, salicylate modulates outer membrane 
proteins, virulence factors, and reduces motility. In addition, NaSal is able induce 
“phenotypic antibiotic resistance” by binding to MarR and de-repressing the mar 
operon. NaSal promotes the dissociation of MarR from the promoter site leading to 
transcription of MarA, a transcription factor that induces several genes that encode 
the AcrAB-TolC pump which effluxes multiple antibiotics from the cell. 
 
 
The present study investigates the possible roles of ATP-dependent proteases, Lon 
and Clp, during growth reduction of E. coli induced with high (2-3 mM) amounts of 
NaSal. The growth of the Lon mutant (lon), but not clpP, was found to be greatly 
reduced with high doses of NaSal in the media. Our hypothesis was that the lack of 
Lon led to the accumulation of high amounts of substrate proteins, which led to its 
greater sensitivity with high doses of NaSal. To identify the substrate protein/s and to 
better understand the mechanism of action, single and double mutants (with lon) of 
E. coli lacking several prominent Lon substrates, i.e. MarA, RcsA, StpA, SulA and UmuD, 
were generated and screened for rescue of growth with 2-3 mM NaSal. MarA, a 
transcription factor, was identified to be important during NaSal-induced growth 
reduction. It modulates outer membrane proteins and induces the AcrAB-TolC pump 
that increases the efflux of antibiotics from the cell. Also, RT-PCR analysis revealed 
that the levels of marA and its targets, acrA and acrB, were higher in the lon strain 
suggesting that the MarA protein levels were stabilised the cell in the absence of Lon. 
Further studies using approriate strains demonstrated that one of the effectors of 
MarA, i.e. the AcrAB-TolC efflux pump, was not involved in the NaSal-induced growth 
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inhibition of lon. Therefore, in presence of higher doses of NaSal, MarA is 
upregulated due to de-repression of the operon. The levels of MarA are regulated by 
Lon via degradation but in the absence of Lon, MarA levels are stabilised and lead to 
upregulation of MarA and its target genes like AcrAB-TolC. This study identifies higher 
amounts of MarA to be responsible for NaSal-induced growth inhibition of lon. 
 
 
Subsequently, experiments were conducted to demonstrate the role of MarA and its 
targets in antibiotic resistance with low dose (0.5 mM) NaSal that does not affect 
growth. This low dose of NaSal was able to upregulate marA and its target genes, acrA, 
acrB and tolC. Quantification of antibiotic resistance further revealed an induction in 
resistance by 0.5 mM NaSal in a MarA- and AcrB-dependent fashion. Studies using 
atomic force microscopy demonstrated that ciprofloxacin-induced cell elongation was 
lower in lon due to higher levels of MarA. Therefore, low dose of NaSal is capable of 
upregulating MarA and inducing antibiotic resistance but does not affect cell growth. 
This part of the study addresses the roles of Lon protease, its substrate MarA and 
MarA-induced targets, e.g. AcrB, during NaSal-mediated growth reduction and 
antibiotic resistance. 
 
 
The factors contributing to antibiotic resistance in bacteria are an important area of 
study for the global public health care system. Antibiotic resistance can be acquired by 
transmittance of genetic material, accumulation of antibiotic resistant mutations in 
the target molecule or can be induced by certain compounds present in the 
environment like NaSal. For rapid identification of compounds that may behave in a 
similar fashion as NaSal, a 96-well plate based screen was developed utilising the 
growth inhibition feature of the lon strain. The compounds were selected on the 
basis of their structural (phenolic compounds) and functional (Non-Steroidal Anti 
Inflammatory Drugs or NSAIDs) similarity to NaSal. Through this screen, four 
compounds were identified that lowered the growth of lon more than that of wild 
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type strain and may be important in inducing phenotypic antibiotic resistance: 
Acetaminophen (anti-pyretic), Ibuprofen (NSAID), and two phenolic uncouplers, 
Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) and 2,4-dinitrophenol (2,4-DNP). 
Notably, another compound Phenylbutazone (NSAID), which is used to lower 
inflammation in animals, did not reduce the growth of E. coli. RNA expression analysis 
revealed that these four compounds, but not phenylbutazone, induced the expression 
of marA and its target gene involved in antibiotic efflux, acrB. Furthermore, dose 
dependent and comparative studies with Nasal demonstrated differential effects of 
these four compounds in inducing antibiotic resistance with respect to ciprofloxacin, 
tetracycline and nalidixic acid. The two uncouplers were much more effective in 
inducing antibiotic resistance at lower doses than the NSAIDs. As NSAIDs are clinically 
important compounds, the study suggests that it would be desirable to screen them 
for induction of antibiotic resistance. The approach elucidated in this study has the 
potential to identify additional compounds present in the environment that may 
contribute to antibiotic resistance in bacteria. 
 
 
Overall, this study delineates the roles of Lon protease and its substrate, MarA, during 
NaSal-mediated responses, involving antibiotic resistance and/or growth reduction in 
E. coli. In addition, four other compounds were identified that could induce 
phenotypic antibiotic resistance in E. coli in a MarA-dependent manner. These 
observations may have implications in the adaptation of bacteria under different 
environmental conditions. 
  
